Medtronic has recalled the TurboHawk Plus directional atherectomy system, used in the peripheral arteries, due to the risk of catheter-tip damage during use, the US Food and Drug Administration ...

Medtronic Plc (NYSE: MDT) has initiated a voluntary recall to customers related to the risk associated with tip damage caused by guidewire prolapse in its 6 French (6Fr) TurboHawk Plus Directional ...

Medtronic and the FDA are expanding the reach of a Class I recall handed down in January for the medtech giant’s catheter designed to clear out clogged arteries. The previous recall covered more than ...

Editor's note: In an earlier version of this story, TurboHawk was misspelled. MD+DI regrets the error. Earlier this year, Medtronic recalled its HawkOne Directional ...

Study Confirms Effectiveness of Directional Atherectomy with SilverHawk ™ and TurboHawk ™ Devices as a Frontline Therapy when Treating PAD LAS VEGAS--(BUSINESS WIRE)-- Covidien (NYSE:COV), a leading ...

A new surgical device with a super-hero sounding name is saving limbs and lives one artery at a time. The Turbohawk is a motorized catheterization device that scrapes and collects plaque and powers ...

Medtronic has recalled 686 TurboHawk Plus Directional Atherectomy Systems because there is a risk that the guidewire within the catheter may move downward or prolapse during use, which may damage the ...

Study Confirms Effectiveness of Directional Atherectomy with SilverHawk ™ and TurboHawk ™ Devices as a Frontline Therapy when Treating PAD DEFINITIVE LE study confirms that directional atherectomy ...

LAS VEGAS--(BUSINESS WIRE)-- Covidien (NYS: COV) , a leading global provider of healthcare products, today announced final 12-month results from its DEFINITIVE LE (Determination of Effectiveness of ...